SCHEMBL675094

SCHEMBL675094

O=C(/C=C/c1ccc(O)cc1O)c1ccc(O)cc1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYR P14679 2/20 1.00
CHRNA7 P36544 7/20 0.81
CAPN1 P07384 1/20 0.70
CTSL P07711 1/20 0.70
CTSB P07858 1/20 0.70
CYP3A4 P08684 3/20 0.70
CYP2C9 P11712 2/20 0.70
NFKB1 P19838 2/20 0.70
CYP2C19 P33261 2/20 0.70
BACE1 P56817 2/20 0.70
MEN1 O00255 2/20 0.70
MAPT P10636 2/20 0.70
HPGD P15428 2/20 0.70
KMT2A Q03164 2/20 0.70
TDP1 Q9NUW8 2/20 0.70
ALOX15 P16050 2/20 0.70
MAPK1 P28482 2/20 0.70
HSD17B10 Q99714 2/20 0.70
GMNN O75496 1/20 0.70
LMNA P02545 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL675095 1.00 TYR (1.00) TYRCHRNA7CAPN1CTSLCTSB
SCHEMBL30383155 0.91 TYR (0.82) TYRCHRNA7CAPN1CTSLCTSB
SCHEMBL29929576 0.88 CHRNA7 (1.00) TYRCHRNA7CAPN1CTSLCTSB
SCHEMBL2977786 0.88 CHRNA7 (1.00) TYRCHRNA7CAPN1CTSLCTSB
SCHEMBL322102 0.88 CHRNA7 (1.00) TYRCHRNA7CAPN1CTSLCTSB
SCHEMBL2977785 0.88 CHRNA7 (1.00) TYRCHRNA7CAPN1CTSLCTSB
SCHEMBL633742 0.88 CHRNA7 (1.00) TYRCHRNA7CAPN1CTSLCTSB
SCHEMBL19236264 0.88 CHRNA7 (1.00) TYRCHRNA7
SCHEMBL9175439 0.87 TYR (0.77) TYRCHRNA7CAPN1CTSLCTSB
SCHEMBL9175445 0.87 TYR (0.77) TYRCHRNA7CAPN1CTSLCTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106008172-B Preparation method and application of effective part with tyrosinase inhibition effect in mulberry twigs 江南大学 2019-06-07 CN claimed
CN-106008172-A Preparation method and application of effective part with tyrosinase inhibition effect in mulberry twigs 江南大学 2016-10-12 CN claimed
CN-104886241-A A browning inhibitor for fresh-cut fruits and vegetables and a preparation method thereof UNIV JIANGNAN 2015-09-09 CN claimed
JP-11349521-A None JP disclosed
CN-113180181-A Browning control method for vacuum-packaged instant lotus root slices 西南科技大学 2021-07-30 CN disclosed
CN-106008172-B Preparation method and application of effective part with tyrosinase inhibition effect in mulberry twigs 江南大学 2019-06-07 CN disclosed
CN-106008172-B Preparation method and application of effective part with tyrosinase inhibition effect in mulberry twigs 江南大学 2019-06-07 CN disclosed
US-20190142940-A1 Method and system for effecting changes in pigmented tissue MOAZED KAMBIZ THOMAS (US) 2019-05-16 US disclosed
CN-104886241-B A kind of fresh-cut fruit and vegetable browning inhibitor and preparation method thereof 江南大学 2018-06-08 CN disclosed
US-9744237-B2 Method and system for effecting changes in pigmented tissue MOAZED KAMBIZ THOMAS (US) 2017-08-29 US disclosed
CN-106008172-A Preparation method and application of effective part with tyrosinase inhibition effect in mulberry twigs 江南大学 2016-10-12 CN disclosed
US-7622563-B2 Process for producing glycoside MITSUI CHEMICALS, INC. (JP) 2009-11-24 US disclosed
US-20050272921-A1 Process for producing glycoside MITSUI CHEMICALS, INC. (JP) 2005-12-08 US disclosed
EP-1544207-A1 PROCESS FOR PRODUCING GLYCOSIDE Mitsui Chemicals, Inc. (JP) 2005-06-22 EP disclosed
US-6737439-B2 ACTIVE CANCER CHEMOPREVENTATIVE AND TREATING AGENTS IN MAMMALS, INCLUDING HUMANS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS 2004-05-18 US disclosed
US-20030125377-A1 Aromatase inhibitors from Broussonetia papyrifera BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS THE 2003-07-03 US disclosed
WO-2003013554-A2 AROMATASE INHIBITORS FROM BROUSSONETIA PAPYRIFERA THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2003-02-20 WO disclosed
EP-0522880-B1 Genetic sequences encoding flavonoid pathway enzymes and uses therefor INT FLOWER DEV PTY LTD (AU) 2001-03-21 EP disclosed
JP-H11349521-A NEW CHALCONE COMPOUND AND PHARMACEUTICAL CONTAINING THE COMPOUND MINOFUAAGEN SEIYAKU:KK 1999-12-21 JP disclosed
EP-0522880-A2 Genetic sequences encoding flavonoid pathway enzymes and uses therefor INTERNATIONAL FLOWER DEVELOPMENTS Pty. Ltd. (AU) 1993-01-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030125377-A1 Aromatase inhibitors from Broussonetia papyrifera CYP19A1, HSD17B11, CYP17A1 TYR 947/4885CHRNA7 3805/4885CAPN1 1037/4885
US-20050272921-A1 Process for producing glycoside HAAO, OGA, MGAM TYR 68/4885CHRNA7 2826/4885CAPN1 3896/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.